Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Role of Antiapoptotic Protein Mcl1 in Graft-Versus-Host Disease

Jose Antonio Bejarano Garcia, Melanie Nufer, Maria Jose Palacios Barea, Beatriz Guijarro-Albaladejo, Inmaculada Carrasco Brocal, Belén Sierro, Estefania Garcia-Guerrero, Maribel Lara Chica, Teresa Caballero, Alfonso Rodríguez-Gil, Jose Antonio Pérez-Simón

Blood (2024) 144 (Supplement 1): 3395.

https://doi.org/10.1182/blood-2024-200823

Published: 2024

Journal Articles

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Blood (2023) 142 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2023-185757

Published: 2023

Journal Articles

New Optimized Academic Anti-BCMA CAR (CARTemis-1): How Does the Manufacturing Process Impact CAR-T Cell Features?

Belén Sierro-Martínez, Virginia Escamilla Gomez, Laura Perez-Ortega, Beatriz Guijarro-Albaladejo, Paola Hernández-Díaz, María de la Rosa-Garrido, Maribel Lara-Chica, Juan Luis Reguera, Luzalba Sanoja Flores, Blanca Arribas-Arribas, Miguel-Ángel Montiel-Aguilera, Gloria Carmona, Maria-Jose Robles, Teresa Caballero, Javier Briones, Hermann Einsele, Michael Hudecek, Jose A. Pérez-Simón, Estefania Garcia-Guerrero

Blood (2023) 142 (Supplement 1): 6866.

https://doi.org/10.1182/blood-2023-186095

Published: 2023

Journal Articles

Stem Cells and Leukemic Stem Cells As a Prognostic Factor in Acute Myeloid Leukemia

Olga Pérez-López, Marta Reinoso Segura, Clara B. Calderon Garcia, Noelia González-Carrasco, María Solé, Eduardo Rodriguez Arboli, Concepción Prats-Martín, Jose González Campos, Jose A. Perez-Simon, Teresa Caballero

Blood (2022) 140 (Supplement 1): 3446–3447.

https://doi.org/10.1182/blood-2022-169528

Published: 2022

Journal Articles

SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome

Jose F. Falantes, Francisco J. Márquez-Malaver, Estrella Carrillo-Cruz, Rosario M Morales-Camacho, Concepción Prats-Martín, Teresa Caballero, Eduardo Rodriguez Arbolí, Ildefonso Espigado, Jose A. Perez-Simon

Blood (2022) 140 (Supplement 1): 6920–6922.

https://doi.org/10.1182/blood-2022-169372

Published: 2022

Journal Articles

Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Blood (2022) 140 (Supplement 1): 880–882.

https://doi.org/10.1182/blood-2022-163394

Published: 2022

Journal Articles

Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic Graft vs. Host Disease: A Report of Two Phase I/II Trials

Eduardo Rodriguez Arbolí, Catherine J. Lee, Teresa Caballero, Clara Garcia-Calderon, Carmen Martinez, Maria Aranzazu Bermudez, Lucía López Corral, Ana Triguero, Lynn E. Onstad, Stefanie Sarantopoulos, Stephanie J. Lee, Jose A. Perez-Simon

Blood (2022) 140 (Supplement 1): 10502–10504.

https://doi.org/10.1182/blood-2022-158230

Published: 2022

Journal Articles

Detection, Monitoring and Cell Kinetics of Circulating CAR-T Cells in B-Cell Malignancies

Belén Sierro, Clara Beatriz Garcia-Calderon, Luzalba Sanoja-Flores, Victoria Ruiz-Maldonado, Javier Delgado Serrano, Agueda Molinos-Quintana, Juan Luis Reguera, Beatriz Guijarro-Albaladejo, Marta Reinoso-Segura, Estefania Garcia-Guerrero, Jose A. Perez-Simon, Teresa Caballero

Blood (2022) 140 (Supplement 1): 7550–7551.

https://doi.org/10.1182/blood-2022-163106

Published: 2022

Journal Articles

Prognosis Value of Measurable Residual Disease By Multiparameter Flow Cytotometry in Patients with Acute Myeloblastic Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation

Teresa Caballero, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo Rodriguez Arbolí, Enrique Colado Varela, Maria Desamparados Sampere Talens, María Belén Vidriales, Covadonga Quirós Caso, Marta Reinoso Segura, Concepción Prats-Martín, Pau Montesinos, Jose A. Perez-Simon

Blood (2021) 138 (Supplement 1): 1821.

https://doi.org/10.1182/blood-2021-151533

Published: 2021

Journal Articles

Cannabinoids Induce Cell Death in Leukemic Cells through Parthanatos and PARP-Related Metabolic Disruptions

Mayte Medrano, Miriam Guadalupe Contreras-Mostazo, Teresa Caballero, Jose Antonio Bejarano-García, Iván V. Rosado, Jose Pérez-Simón

Blood (2021) 138 (Supplement 1): 4340.

https://doi.org/10.1182/blood-2021-151108

Published: 2021

Journal Articles

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

Bruno Paiva, PhD, María Belén Vidriales, Maria Desamparados Sampere Talens, Fabian Tarin, Enrique Colado, Celina Benavente, María Teresa Cedena, MD, Joaquin Sanchez, MD, Teresa Caballero-Velázquez, MD PhD, Lourdes Cordon, David Martínez-Cuadron, MD, Teresa Bernal del Castillo, MD PhD, Carmen Botella, Sofia Grille, MDPhD, Josefina Serrano, MD, Carlos Rodriguez, Jesús Lorenzo Algarra, Juan Manuel Alonso Dominguez, MD PhD MSc, Maria Luz Amigo, MD, Manuel BARRIOS García, MDPhD, Raimundo García-Boyero, MD, Mercedes Colorado, MD, Jaime Perez De Oteyza, MDPhD, Manuel Perez Encinas, MD, Lissette Del Pilar Costilla, MD, Maria Jose Sayas, Olga Pérez-López, Marcos González, Jose A. Perez-Simon, MD PhD, Joaquin Martinez-Lopez, MD PhD, Claudia Lucia Sossa, Alberto Orfao, MD PhD, Jesús F. San-Miguel, Miguel Sanz, MD PhD, Pau Montesinos, MD PhD

Blood (2020) 136 (Supplement 1): 13–15.

https://doi.org/10.1182/blood-2020-134349

Published: 2020

Journal Articles

Identification and Isolation of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients through the Identification of T-Cells Capable to Establish Stable Interactions with Leukemic Cells

Estefania Garcia-Guerrero, Luis I. Sanchez-Abarca, PhD, Esther Domingo, PhD, Teresa Ramos, PhD, Jose Antonio Bejarano-García, Jose A Gonzalez-Campos, MD, Teresa Caballero-Velázquez, MD PhD, José A. Pérez-Simón, MD PhD

Blood (2018) 132 (Supplement 1): 3336.

https://doi.org/10.1182/blood-2018-99-118118

Published: 2018

Journal Articles

Pre-Clinical Trial to Evaluate the Efficacy of Delayed Administration of Ixazomib in the Prophylaxis of Chronic Graft-Versus-Host Disease

Teresa Ramos, PhD, Alfonso Rodríguez-Gil, PhD, Melanie Nufer, María Victoria Barbado, PhD, Estefania Garcia Guerrero, PhD, Rocio Caracuel-García, Tehcnician, Teresa Caballero-Velázquez, MD PhD, José A. Pérez-Simón, MD PhD

Blood (2018) 132 (Supplement 1): 4521.

https://doi.org/10.1182/blood-2018-99-118098

Published: 2018

Journal Articles

Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Olga Pérez-López, MD, Teresa Caballero-Velázquez, MD PhD, Enrique Colado, MD PhD, Sara Alonso, MD, José González-Campos, MD, Concepción Prats-Martín, MD, Nancy Rodríguez-Torres, MD, Virginia Escamilla Gomez, Ildefonso Espigado, MD PhD, Jose Antonio Pérez-Simón

Blood (2018) 132 (Supplement 1): 5733.

https://doi.org/10.1182/blood-2018-99-119437

Published: 2018

Journal Articles

Influence of VDR Polymorphisms on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) within the Alovita Trial.

Estrella Carrillo-Cruz, MD, Teresa Caballero-Velázquez, MD PhD, Isabel Montero, MD, Fermin Sanchez-Guijo, MD PhD, Miguel Alcoceba, PhD, Christelle Marie Ferra I Coll, David Valcarcel, Rocio Parody, MD, Lucia Lopez Corral, Oriana López-Godino, Marian Cuesta, Francisco Marquez, Teresa Ramos, José Raúl Garcia-Lozano, José A. Pérez-Simón

Blood (2017) 130 (Supplement 1): 3251.

https://doi.org/10.1182/blood.V130.Suppl_1.3251.3251

Published: 2017

Journal Articles

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Eduardo Rodríguez-Arbolí, MD, Francisco J. Márquez-Malaver, RN, Nancy Rodríguez-Torres, MD, Teresa Caballero-Velázquez, MD PhD, Virginia Escamilla Gomez, Cristina Calderón-Cabrera, MD, José F. Falantes, MD, Ildefonso Espigado, MD PhD, José A. Pérez-Simón

Blood (2017) 130 (Supplement 1): 5548.

https://doi.org/10.1182/blood.V130.Suppl_1.5548.5548

Published: 2017

Journal Articles

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Blood (2017) 130 (Supplement 1): 1983.

https://doi.org/10.1182/blood.V130.Suppl_1.1983.1983

Published: 2017

Journal Articles

Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids

Mayte Medrano, María Victoria Barbado-Gonzalez, Nuria Campillo, Francisco Hidalgo, Teresa Caballero-Velazquez, Olga Perez-Lopez, Maria Sole-Rodriguez, Jose Ignacio Piruat-Palomo, Jose A. Perez-Simon, MD, PhD

Blood (2016) 128 (22): 4718.

https://doi.org/10.1182/blood.V128.22.4718.4718

Published: 2016

Journal Articles

Response to Proteosome Inhibitors and Immunomodulatory Drugs before and after Allogeneic Transplantation in Patients with Multiple Myeloma: A Long Term Follow up Study

Blood (2016) 128 (22): 3436.

https://doi.org/10.1182/blood.V128.22.3436.3436

Published: 2016

Journal Articles

Clinical Outcome, Molecular and Gene Expression Analysis of 20 MLL-Rearranged AML from a Single Institution

Sergio Burillo-Sanz, PhD, Rosario Morales-Camacho, MD PhD, MT Vargas, Prof., Javier Sánchez, PhD, Jose Raul Garcia-Lozano, MD PhD, Teresa Caballero-Velazquez, MD PhD, Concepcion Prats-Martin, MD, Olga Perez, MD, Ricardo Bernal, MD PhD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 4943.

https://doi.org/10.1182/blood.V126.23.4943.4943

Published: 2015

NARROW

Role of Antiapoptotic Protein Mcl1 in Graft-Versus-Host Disease

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

New Optimized Academic Anti-BCMA CAR (CARTemis-1): How Does the Manufacturing Process Impact CAR-T Cell Features?

Stem Cells and Leukemic Stem Cells As a Prognostic Factor in Acute Myeloid Leukemia

SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome

Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic Graft vs. Host Disease: A Report of Two Phase I/II Trials

Detection, Monitoring and Cell Kinetics of Circulating CAR-T Cells in B-Cell Malignancies

Prognosis Value of Measurable Residual Disease By Multiparameter Flow Cytotometry in Patients with Acute Myeloblastic Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation

Cannabinoids Induce Cell Death in Leukemic Cells through Parthanatos and PARP-Related Metabolic Disruptions

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

Identification and Isolation of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients through the Identification of T-Cells Capable to Establish Stable Interactions with Leukemic Cells

Pre-Clinical Trial to Evaluate the Efficacy of Delayed Administration of Ixazomib in the Prophylaxis of Chronic Graft-Versus-Host Disease

Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Influence of VDR Polymorphisms on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) within the Alovita Trial.

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Cannabinoids Derivatives Exert a Potent Antileukemic Effect By Modifying the Pattern of Membrane Sphingolipids

Response to Proteosome Inhibitors and Immunomodulatory Drugs before and after Allogeneic Transplantation in Patients with Multiple Myeloma: A Long Term Follow up Study

Clinical Outcome, Molecular and Gene Expression Analysis of 20 MLL-Rearranged AML from a Single Institution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only